Pentolair en es it fr

Pentolair Brand names, Pentolair Analogs

Pentolair Brand Names Mixture

  • No information avaliable

Pentolair Chemical_Formula


Pentolair RX_link

No information avaliable

Pentolair fda sheet

Pentolair msds (material safety sheet)

Pentolair MSDS

Pentolair Synthesis Reference

No information avaliable

Pentolair Molecular Weight

291.385 g/mol

Pentolair Melting Point

139 oC (hydrochloride salt)

Pentolair H2O Solubility

No information avaliable

Pentolair State


Pentolair LogP


Pentolair Dosage Forms

Ophthalmic solution (eye drops)

Pentolair Indication

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

Pentolair Pharmacology

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

Pentolair Absorption

Absorbed following ophthalmic administration.

Pentolair side effects and Toxicity

Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

Pentolair Patient Information

No information avaliable

Pentolair Organisms Affected

Humans and other mammals